Image source: Getty Images Judging by the headlines in mainstream media these days, it’s easy to think a horrendous stock market crash is headed our way sooner or later: “Are global stock markets heading for a crash?” – The Guardian “This chart says the stock market is ready to crash”…
Knife River urged to explore sale by activist Starboard Value – WSJ (KNF:NYSE)
ewg3D/E+ via Getty Images Knife River (KNF) rises 5.3% post-market Wednesday after The Wall Street Journal reported that activist investor Starboard Value has built a significant stake in the company and plans to push for a sale or an improvement in its margins. Starboard Source link
Here are the major earnings before the open Thursday
Here are the major earnings before the open Thursday Source link
Viking Therapeutics files plans for $400M in combined offerings of common stock, convertible notes
Viking Therapeutics (VKTX) on Wednesday said that it intends to offer $200M of common stock and $200M aggregate principal amount of convertible senior notes due 2032 in separate public offerings. Viking also expects to grant the underwriters of the common Source link
Restoring Fed independence is high priority for Warsh, NEC director Hassett says
Federal Reserve Chair Kevin Warsh is “managing an unusually partisan Fed,” Kevin Hassett, director of the National Economic Council, said on Wednesday. Part of that he blamed on Jerome Powell not resigning after his term as Fed chair ended. Also, Michael Barr, who Source link
Kalshi says it is not being investigated by the CFTC over trading activity
The activity had already drawn attention from Beni, a co-founder of research firm Stealth Neolab, who said Kalshi’s ether perpetual recorded about $539 million in 24-hour volume against just $3.1 million in open interest. He later found that trades of exactly $5,500 made up 48% to 58% of notional volume…
PG&E drops to nearly four-year low after UBS downgrades as wildfire reform catalyst fades (PCG:NYSE)
Justin Sullivan/Getty Images News PG&E (PCG) slides 3.5% in Wednesday’s trading to its lowest since September 2022 as UBS downgraded the California utility company to Neutral from Buy with a $14 price target, cut from $19, citing a growing risk of inaction on wildfire liability reform Source link
Oruka posts trial data for plaque psoriasis drug (ORKA:NASDAQ)
IvelinRadkov Shares of Oruka Therapeutics (ORKA) traded lower on Wednesday after updated data from a mid-stage trial for ORKA-001, its candidate for the autoimmune skin condition plaque psoriasis, fell short of expectations. Announcing 28-week data from its EVERLAST-A Phase 2a trial, the Source link
Inside the FBI’s under-the-radar crypto crime symposium
Although the symposium is not secret, it has received little media attention. Its public footprint consists largely of occasional posts from attendees rather than prominent FBI announcements or the publicity campaigns typical of commercial crypto conferences. A LinkedIn post published by Token Recovery executive Roman Bieda confirms that the 2024…
EU extends review of Kimberly-Clark’s $40B Kenvue deal (KMB:NASDAQ)
skhoward Kimberly-Clark (KMB) has offered concessions to address European Union antitrust concerns over its $40 billion acquisition of Kenvue (KVUE), Reuters reported on Wednesday, citing a European Commission filing. The European Commission did not disclose details of the proposed remedies, in line Source link